![Richard Lesniewski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Lesniewski
Fondatore presso Madison Vaccines, Inc.
Posizioni attive di Richard Lesniewski
Società | Posizione | Inizio | Fine |
---|---|---|---|
Madison Vaccines, Inc.
![]() Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Fondatore | 01/01/2012 | - | |
Presidente | 01/01/2012 | - | |
DNASTAR, Inc.
![]() DNASTAR, Inc. Packaged SoftwareTechnology Services DNASTAR, Inc. is a bioinformatics software company that has been innovating since 1984. The private company is based in Madison, WI. The company's flagship product, Lasergene, provides a comprehensive software solution for life science researchers. | Direttore/Membro del Consiglio | - | - |
Scarab Genomics LLC
![]() Scarab Genomics LLC BiotechnologyHealth Technology Scarab Genomics LLC specializes in providing the most robust bacterial fermentation host for general/routine recombinant protein expression and nucleic acid production. The private company is based in Madison, WI and was founded by Trevor M. Twose. The company's Clean Genome® technology reduces the mutation rate to almost zero, even under the most stressful conditions. Scarab Genomics offers Clean Genome® LowMut T7, which provides a T7 promoter in the genome for clients wishing to use this expression option rather than the recommended synthetic T5 promoter in the pSX2 vector. Scarab Genomics also offers an insertion sequence (IS) detection kit that tests for the presence of all known E. coli IS elements in any DNA sample of interest. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Richard Lesniewski
Precedenti posizioni note di Richard Lesniewski
Società | Posizione | Inizio | Fine |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/01/2009 | 01/01/2009 |
GSK PLC | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Settori
Health Technology | 5 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
GSK PLC | Health Technology |
Aziende private | 3 |
---|---|
Madison Vaccines, Inc.
![]() Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI. | Health Technology |
DNASTAR, Inc.
![]() DNASTAR, Inc. Packaged SoftwareTechnology Services DNASTAR, Inc. is a bioinformatics software company that has been innovating since 1984. The private company is based in Madison, WI. The company's flagship product, Lasergene, provides a comprehensive software solution for life science researchers. | Technology Services |
Scarab Genomics LLC
![]() Scarab Genomics LLC BiotechnologyHealth Technology Scarab Genomics LLC specializes in providing the most robust bacterial fermentation host for general/routine recombinant protein expression and nucleic acid production. The private company is based in Madison, WI and was founded by Trevor M. Twose. The company's Clean Genome® technology reduces the mutation rate to almost zero, even under the most stressful conditions. Scarab Genomics offers Clean Genome® LowMut T7, which provides a T7 promoter in the genome for clients wishing to use this expression option rather than the recommended synthetic T5 promoter in the pSX2 vector. Scarab Genomics also offers an insertion sequence (IS) detection kit that tests for the presence of all known E. coli IS elements in any DNA sample of interest. | Health Technology |
- Borsa valori
- Insiders
- Richard Lesniewski
- Esperienza